Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
5097 | 1673 | 34.7 | 60% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
159 | 3 | MENOPAUSE//ISOFLAVONES//TAMOXIFEN | 61134 |
329 | 2 | TAMOXIFEN//ESTROGEN RECEPTOR//AROMATASE INHIBITORS | 18133 |
5097 | 1 | AROMATASE INHIBITORS//ANASTROZOLE//EXEMESTANE | 1673 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | AROMATASE INHIBITORS | authKW | 467841 | 9% | 16% | 157 |
2 | ANASTROZOLE | authKW | 411084 | 6% | 23% | 96 |
3 | EXEMESTANE | authKW | 356909 | 4% | 27% | 72 |
4 | VOROZOLE | authKW | 311418 | 1% | 74% | 23 |
5 | AROMATASE INHIBITOR | authKW | 307839 | 7% | 15% | 111 |
6 | FORMESTANE | authKW | 214691 | 1% | 59% | 20 |
7 | LETROZOLE | authKW | 199737 | 5% | 13% | 83 |
8 | AMINOGLUTETHIMIDE | authKW | 197855 | 2% | 36% | 30 |
9 | AROMATASE | authKW | 86148 | 6% | 5% | 94 |
10 | THER EUT ONCOL RADIOPHYS | address | 76041 | 0% | 83% | 5 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Oncology | 16735 | 52% | 0% | 863 |
2 | Endocrinology & Metabolism | 1787 | 14% | 0% | 227 |
3 | Pharmacology & Pharmacy | 1078 | 17% | 0% | 283 |
4 | Chemistry, Medicinal | 976 | 8% | 0% | 131 |
5 | Biochemistry & Molecular Biology | 126 | 12% | 0% | 200 |
6 | Chemistry, Analytical | 64 | 4% | 0% | 71 |
7 | Medicine, General & Internal | 62 | 5% | 0% | 77 |
8 | Obstetrics & Gynecology | 55 | 3% | 0% | 43 |
9 | Toxicology | 27 | 2% | 0% | 34 |
10 | Biochemical Research Methods | 21 | 2% | 0% | 37 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | THER EUT ONCOL RADIOPHYS | 76041 | 0% | 83% | 5 |
2 | DRUG DISCOVERY MED CHEM 3 | 36500 | 0% | 100% | 2 |
3 | HORMONES CANC PROGRAM | 36500 | 0% | 100% | 2 |
4 | CNRSEP 9 | 24332 | 0% | 67% | 2 |
5 | HAUKELAND HOSP ONCOL | 24332 | 0% | 67% | 2 |
6 | UP EA BIOMOL THER IES ANTITUMORALES 4021 | 24332 | 0% | 67% | 2 |
7 | SECT ONCOL | 20270 | 2% | 4% | 28 |
8 | AKH WIENINNERE MED KLIN 1 | 18250 | 0% | 100% | 1 |
9 | ARETEIOU HOSP | 18250 | 0% | 100% | 1 |
10 | ASTMENT ONCOL | 18250 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY | 32610 | 8% | 1% | 127 |
2 | BREAST CANCER RESEARCH AND TREATMENT | 15657 | 5% | 1% | 79 |
3 | EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY | 8678 | 2% | 2% | 30 |
4 | ENDOCRINE-RELATED CANCER | 5802 | 1% | 1% | 23 |
5 | CANCER TREATMENT REPORTS | 5557 | 2% | 1% | 26 |
6 | SEMINARS IN ONCOLOGY | 5276 | 2% | 1% | 39 |
7 | CHEMIOTERAPIA | 5093 | 1% | 3% | 10 |
8 | ONCOLOGY | 5006 | 2% | 1% | 33 |
9 | CANCER CHEMOTHERAPY AND PHARMACOLOGY | 4752 | 3% | 1% | 44 |
10 | EUROPEAN JOURNAL OF CANCER | 3323 | 3% | 0% | 43 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | AROMATASE INHIBITORS | 467841 | 9% | 16% | 157 | Search AROMATASE+INHIBITORS | Search AROMATASE+INHIBITORS |
2 | ANASTROZOLE | 411084 | 6% | 23% | 96 | Search ANASTROZOLE | Search ANASTROZOLE |
3 | EXEMESTANE | 356909 | 4% | 27% | 72 | Search EXEMESTANE | Search EXEMESTANE |
4 | VOROZOLE | 311418 | 1% | 74% | 23 | Search VOROZOLE | Search VOROZOLE |
5 | AROMATASE INHIBITOR | 307839 | 7% | 15% | 111 | Search AROMATASE+INHIBITOR | Search AROMATASE+INHIBITOR |
6 | FORMESTANE | 214691 | 1% | 59% | 20 | Search FORMESTANE | Search FORMESTANE |
7 | LETROZOLE | 199737 | 5% | 13% | 83 | Search LETROZOLE | Search LETROZOLE |
8 | AMINOGLUTETHIMIDE | 197855 | 2% | 36% | 30 | Search AMINOGLUTETHIMIDE | Search AMINOGLUTETHIMIDE |
9 | AROMATASE | 86148 | 6% | 5% | 94 | Search AROMATASE | Search AROMATASE |
10 | CGS 20267 | 73001 | 0% | 100% | 4 | Search CGS+20267 | Search CGS+20267 |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | LONNING, PE , (2003) CLINICAL PHARMACOKINETICS OF AROMATASE INHIBITORS AND INACTIVATORS.CLINICAL PHARMACOKINETICS. VOL. 42. ISSUE 7. P. 619 -631 | 96 | 86% | 9 |
2 | GHOSH, D , LO, J , EGBUTA, C , (2016) RECENT PROGRESS IN THE DISCOVERY OF NEXT GENERATION INHIBITORS OF AROMATASE FROM THE STRUCTURE-FUNCTION PERSPECTIVE.JOURNAL OF MEDICINAL CHEMISTRY. VOL. 59. ISSUE 11. P. 5131 -5148 | 85 | 53% | 1 |
3 | GIBSON, L , LAWRENCE, D , DAWSON, C , BLISS, J , (2009) AROMATASE INHIBITORS FOR TREATMENT OF ADVANCED BREAST CANCER IN POSTMENOPAUSAL WOMEN.COCHRANE DATABASE OF SYSTEMATIC REVIEWS. VOL. . ISSUE 4. P. - | 64 | 76% | 55 |
4 | BUZDAR, A , HOWELL, A , (2001) ADVANCES IN AROMATASE INHIBITION: CLINICAL EFFICACY AND TOLERABILITY IN THE TREATMENT OF BREAST CANCER.CLINICAL CANCER RESEARCH. VOL. 7. ISSUE 9. P. 2620 -2635 | 59 | 94% | 76 |
5 | NJAR, VCO , BRODIE, AMH , (1999) COMPREHENSIVE PHARMACOLOGY AND CLINICAL EFFICACY OF AROMATASE INHIBITORS.DRUGS. VOL. 58. ISSUE 2. P. 233 -255 | 83 | 69% | 65 |
6 | GIBSON, LJ , DAWSON, CL , LAWRENCE, DJ , BLISS, JM , (2007) AROMATASE INHIBITORS FOR TREATMENT OF ADVANCED BREAST CANCER IN POSTMENOPAUSAL WOMEN.COCHRANE DATABASE OF SYSTEMATIC REVIEWS. VOL. . ISSUE 1. P. - | 55 | 81% | 37 |
7 | LONNING, PE , (2002) AROMATASE INHIBITORS AND INACTIVATORS FOR BREAST CANCER THERAPY.DRUGS & AGING. VOL. 19. ISSUE 4. P. 277 -298 | 97 | 52% | 7 |
8 | LONNING, P , PFISTER, C , MARTONI, A , ZAMAGNI, C , (2003) PHARMACOKINETICS OF THIRD-GENERATION AROMATASE INHIBITORS.SEMINARS IN ONCOLOGY. VOL. 30. ISSUE 4. P. 23 -32 | 53 | 84% | 24 |
9 | BRUEGGEMEIER, RW , HACKETT, JC , DIAZ-CRUZ, ES , (2005) AROMATASE INHIBITORS IN THE TREATMENT OF BREAST CANCER.ENDOCRINE REVIEWS. VOL. 26. ISSUE 3. P. 331-345 | 65 | 49% | 240 |
10 | JOHNSON, PE , BUZDAR, A , (2001) ARE DIFFERENCES IN THE AVAILABLE AROMATASE INHIBITORS AND INACTIVATORS SIGNIFICANT?.CLINICAL CANCER RESEARCH. VOL. 7. ISSUE 12. P. 4360S -4368S | 48 | 100% | 7 |
Classes with closest relation at Level 1 |